Financial & competing interests disclosure
Writing assistance was provided by Steve Clissold PhD (Content Ed Net), with funding by Schering-Plough, USA. K Reich has acted as paid speaker and consultant for Abbot, Biogen-Idec, Centocor, Serono, Wyeth and Schering-Plough. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Notes
Rheumatological assessment in 1511 psoriasis patients included in a German epidemiological study Citation[7].
PsA: Psoriatic arthritis.
PASI-50/75/90 signifies a 50, 75 or 90% reduction in PASI compared with pretreatment.
DLQI: Dermatology Life Quality Index; PASI: Psoriasis Activity and Severity Index; QoL: Quality of life.